
Brain Health For The Next Generation
neuroLytixs is a Canadian biotech and medical technology company developing AI-powered blood-based diagnostic tests for concussion detection in youth and amateur sports. Their proprietary test leverages artificial intelligence to analyze blood metabolites and lipids, achieving up to 96% accuracy in diagnosing concussions within 48 hours. Founded by CEO Peter George, CFO Adrian Uthay, and Chief Medical Officer Dr. Douglas Fraser at Western University, the company aims to revolutionize concussion diagnosis and return-to-play decision-making in organized sports.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account